Tomorrow at the 17th Bioshares Biotech Summit in Hobart Tasmania, participants will be introduced to Professor Yuman Fong who will be in attendance as the keynote speaker.
Imugene shareholders already have a unique insight into the genius of Professor Yuman Fong, inventor of the CF33 oncolytic virus. We have been fortunate to learn from the recent roadshow presentations in Sydney and Melbourne and the Invester Webinar last week.
Recent themes from Yuman's quotes cited at the presentations last week include -
- trials have demonstrated that it clearly kills cancer
- we are now seeing in humans what we saw in the lab and in mice
- Vaxinia is "killing cancer" and changing the tumour micro-environment
so that the immune system sees and attacks the cancer as well.
I will be very interested to learn how participants receive Yuman's presentation on the development of Oncolytic Viruses and his insights into recent developments and opportunities in Biotech.
I am expecting they will be extremely impressed with his presentation.
.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Corporate Presentation
Ann: Imugene Corporate Presentation, page-218
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $1.863M | 31.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 0.057 |
14 | 1550875 | 0.056 |
26 | 4138021 | 0.055 |
9 | 1730287 | 0.054 |
4 | 131036 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 60000 | 1 |
0.059 | 708216 | 4 |
0.060 | 1196314 | 8 |
0.061 | 471000 | 3 |
0.062 | 236412 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online